Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria E Rodriguez-Ruiz

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Journal for Immunotherapy of Cancer|May 4, 2026
Cancer-associated fibroblast targeting therapies as a tool to enhance responses to radiotherapy and immunotherapyEneko Garate-Soraluze, Iñigo Martinez-Zubiaurre, Maria E Rodriguez-Ruiz
Nature Cancer|June 28, 2022
Charting roadmaps towards novel and safe synergistic immunotherapy combinationsMiguel F Sanmamed, Pedro Berraondo, Maria E Rodriguez-Ruiz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2017
Anti-CD137 and PD-1/PD-L1 Antibodies En Route toward Clinical SynergyElisabeth Pérez-Ruiz, Iñaki Etxeberria, Maria E Rodriguez-Ruiz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2021
Consolidating Radiotherapy with ImmunotherapyMaria E Rodriguez-Ruiz, Miguel F Sanmamed, Irantzu Serrano-Mendioroz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2016
Emerging Opportunities and Challenges in Cancer ImmunotherapyTheresa L Whiteside, Sandra Demaria, Maria E Rodriguez-Ruiz, et al.
Cancer Immunology, Immunotherapy : CII|March 14, 2016
Anti-CD137 monoclonal antibodies and adoptive T cell therapy: a perfect marriage?Bettina Weigelin, Elixabet Bolaños, Maria E Rodriguez-Ruiz, et al.
Current Opinion in Immunology|February 4, 2014
Orchestrating immune check-point blockade for cancer immunotherapy in combinationsJose Luis Perez-Gracia, Sara Labiano, Maria E Rodriguez-Ruiz, et al.
Head & Neck|January 24, 2012
Comparison of limited-volume perioperative high-dose-rate brachytherapy and wide-field external irradiation in resected head and neck cancerMiren Gaztañaga, María Pagola, Mauricio Cambeiro, et al.
Seminars in Oncology|August 31, 2015
Agonists of Co-stimulation in Cancer Immunotherapy Directed Against CD137, OX40, GITR, CD27, CD28, and ICOSMiguel F Sanmamed, Fernando Pastor, Alfonso Rodriguez, et al.
Immunological Reviews|October 12, 2023
Cytotoxicity as a form of immunogenic cell death leading to efficient tumor antigen cross-primingCarlos Luri-Rey, Gabriel Gomis, Javier Glez-Vaz, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Journal for Immunotherapy of Cancer|May 4, 2026
Cancer-associated fibroblast targeting therapies as a tool to enhance responses to radiotherapy and immunotherapyEneko Garate-Soraluze, Iñigo Martinez-Zubiaurre, Maria E Rodriguez-Ruiz
Nature Cancer|June 28, 2022
Charting roadmaps towards novel and safe synergistic immunotherapy combinationsMiguel F Sanmamed, Pedro Berraondo, Maria E Rodriguez-Ruiz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2017
Anti-CD137 and PD-1/PD-L1 Antibodies En Route toward Clinical SynergyElisabeth Pérez-Ruiz, Iñaki Etxeberria, Maria E Rodriguez-Ruiz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2021
Consolidating Radiotherapy with ImmunotherapyMaria E Rodriguez-Ruiz, Miguel F Sanmamed, Irantzu Serrano-Mendioroz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2016
Emerging Opportunities and Challenges in Cancer ImmunotherapyTheresa L Whiteside, Sandra Demaria, Maria E Rodriguez-Ruiz, et al.
Cancer Immunology, Immunotherapy : CII|March 14, 2016
Anti-CD137 monoclonal antibodies and adoptive T cell therapy: a perfect marriage?Bettina Weigelin, Elixabet Bolaños, Maria E Rodriguez-Ruiz, et al.
Current Opinion in Immunology|February 4, 2014
Orchestrating immune check-point blockade for cancer immunotherapy in combinationsJose Luis Perez-Gracia, Sara Labiano, Maria E Rodriguez-Ruiz, et al.
Head & Neck|January 24, 2012
Comparison of limited-volume perioperative high-dose-rate brachytherapy and wide-field external irradiation in resected head and neck cancerMiren Gaztañaga, María Pagola, Mauricio Cambeiro, et al.
Seminars in Oncology|August 31, 2015
Agonists of Co-stimulation in Cancer Immunotherapy Directed Against CD137, OX40, GITR, CD27, CD28, and ICOSMiguel F Sanmamed, Fernando Pastor, Alfonso Rodriguez, et al.
Immunological Reviews|October 12, 2023
Cytotoxicity as a form of immunogenic cell death leading to efficient tumor antigen cross-primingCarlos Luri-Rey, Gabriel Gomis, Javier Glez-Vaz, et al.
Pageof 4